Pell Bio-Med Technology Statistics

Total Valuation

TPE:6949 has a market cap or net worth of TWD 20.48 billion. The enterprise value is 19.97 billion.

Market Cap	20.48B
Enterprise Value	19.97B

Important Dates

The last earnings date was Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TPE:6949 has 58.35 million shares outstanding. The number of shares has increased by 12.03% in one year.

Current Share Class	58.35M
Shares Outstanding	58.35M
Shares Change (YoY)	+12.03%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	16.79%
Owned by Institutions (%)	n/a
Float	27.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	746.63
PB Ratio	17.91
P/TBV Ratio	19.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-56.07
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-31.80

Financial Position

The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.31.

Current Ratio	2.51
Quick Ratio	2.46
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	-0.56
Interest Coverage	-93.98

Financial Efficiency

Return on equity (ROE) is -28.12% and return on invested capital (ROIC) is -15.26%.

Return on Equity (ROE)	-28.12%
Return on Assets (ROA)	-13.75%
Return on Invested Capital (ROIC)	-15.26%
Return on Capital Employed (ROCE)	-30.08%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	6.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +245.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+245.81%
50-Day Moving Average	187.97
200-Day Moving Average	130.76
Relative Strength Index (RSI)	78.05
Average Volume (20 Days)	327,578

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPE:6949 had revenue of TWD 27.43 million and -356.15 million in losses. Loss per share was -6.12.

Revenue	27.43M
Gross Profit	-5.36M
Operating Income	-380.98M
Pretax Income	-367.02M
Net Income	-356.15M
EBITDA	-361.35M
EBIT	-380.98M
Loss Per Share	-6.12

Full Income Statement

Balance Sheet

The company has 961.48 million in cash and 351.10 million in debt, giving a net cash position of 610.39 million or 10.46 per share.

Cash & Cash Equivalents	961.48M
Total Debt	351.10M
Net Cash	610.39M
Net Cash Per Share	10.46
Equity (Book Value)	1.14B
Book Value Per Share	17.85
Working Capital	593.53M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -287.56 million and capital expenditures -340.38 million, giving a free cash flow of -627.95 million.

Operating Cash Flow	-287.56M
Capital Expenditures	-340.38M
Free Cash Flow	-627.95M
FCF Per Share	-10.76

Full Cash Flow Statement

Margins

Gross Margin	-19.52%
Operating Margin	-1,388.81%
Pretax Margin	-1,337.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPE:6949 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.03%
Shareholder Yield	n/a
Earnings Yield	-1.74%
FCF Yield	-3.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3